Aily Labs Raises $80M In Funding Led By FPV Ventures

Listen to this article

Aily Labs raised $80 million in a Series B round, bringing total funding to approximately $101 million. The round was led by FPV Ventures, with participation from existing investor Insight Partners, J.P. Morgan, and other strategic investors. The capital will fuel global expansion, enhancements to the autonomous AI agent ecosystem, and delivering immediate ROI to Fortune 500 clients in sectors like finance, supply chain, R&D, and commercial operations.

Aily Labs develops an AI-native Decision Intelligence platform that integrates enterprise data with AI, machine learning, and large language models to enable faster, data-driven decisions. The platform breaks down silos, providing autonomous AI agents for real-time insights and optimization. It targets large enterprises, emphasizing mobile-first access and measurable outcomes from deployment.

Previous Funding and Growth Trajectory: This Series B follows a €19 million (~$21 million) Series A in August 2023, led by Insight Partners. The rapid progression—less than 2.5 years between rounds—reflects strong market validation amid the AI boom. Valuation remains undisclosed, but the fourfold increase in round size signals investor confidence in scaling potential.

Investor Analysis

• FPV Ventures (Lead): A venture firm focused on enterprise software and AI, this marks their bet on Aily’s agentic AI capabilities for corporate transformation.
• Insight Partners: Retained from Series A, providing continuity and expertise in scaling SaaS platforms globally.
• J.P. Morgan: Adds financial sector credibility, aligning with Aily’s applications in finance and operations.

Market Context and Implications

The AI decision intelligence market is exploding, projected to reach $28.5 billion by 2028 from current levels, driven by demand for autonomous tools in complex enterprises. Aily’s focus on Fortune 500 ROI positions it well against competitors like Palantir and C3.ai, potentially accelerating adoption in regulated industries like pharma (e.g., Sanofi partnership). This funding could enable 2-3x team growth and international hires, though execution risks include integration challenges in legacy systems.

Aily Labs’ latest Series B funding round represents a pivotal inflection point for the company, underscoring its maturation from an innovative AI startup to a scaled enterprise player in the burgeoning decision intelligence space. Launched in 2020 amid the early waves of generative AI adoption, Aily Labs has methodically built a platform that not only aggregates disparate enterprise data but also deploys autonomous AI agents to simulate, predict, and optimize decisions across critical functions. This round injects $80 million into a war chest that now totals $101 million, signaling robust investor appetite for AI solutions that deliver tangible, immediate value in high-stakes corporate environments.

Funding Round Breakdown

The Series B was spearheaded by FPV Ventures, a firm with a track record in backing AI-driven enterprise software that bridges data silos and operational inefficiencies. Joining them were familiar faces like Insight Partners, who led the prior round and bring deep SaaS scaling expertise, as well as J.P. Morgan, whose involvement lends a layer of institutional heft particularly relevant for Aily’s finance-adjacent applications. Other strategic investors rounded out the syndicate, though specifics remain under wraps, suggesting a mix of corporate venture arms or industry insiders eyeing symbiotic partnerships.

While post-money valuation figures have not been disclosed—a common practice in recent AI rounds to maintain competitive edges—the progression from a $21 million Series A to this $80 million infusion implies a valuation likely in the $300-500 million range, based on typical 4-6x multiples for high-growth AI firms at this stage. This capital infusion is earmarked for three core pillars: accelerating global go-to-market efforts, particularly in North America and Europe; advancing the autonomous AI agent ecosystem to handle more complex, multi-step decision workflows; and embedding ROI metrics from day one to fortify client retention among Fortune 500 heavyweights.

This table illustrates the company’s funding cadence, highlighting the accelerated timeline and escalating round sizes that reflect escalating traction in a competitive landscape.

Recommended: How To Use Numerous.ai? Step By Step Guide For Beginners

Company Evolution and Operational Milestones

Aily Labs operates with a 260-person team comprising AI data scientists, engineers, business strategists, and product specialists. The firm’s origins trace back to founder and CEO Bianca Anghelina‘s vision for “agentic AI”—systems that don’t just analyze data but act autonomously to drive outcomes. Early bootstrapping gave way to profitability in the first full year of operations, a rarity in AI startups, fueled by a lean focus on pharma and manufacturing verticals.

By mid-2025, Aily Labs had achieved $28.6 million in annual recurring revenue, underpinned by 500% year-over-year customer growth and thousands of active users. Key traction points include deployments at Sanofi, where the platform—branded internally as “plai”—provides a unified dashboard for R&D and supply chain visibility, yielding unprecedented insights into clinical trial efficiencies and inventory optimization. Other Fortune 500 clients span healthcare, consumer goods, and financial services, with the platform’s mobile-first design enabling executives to query and act on AI-generated scenarios in real time. Recent board expansions, including AI luminaries and industry veterans, further bolster governance for this growth phase.

These metrics, drawn from operational disclosures, paint a picture of a company not just surviving the AI hype cycle but thriving through product-market fit.

Investor Ecosystem and Strategic Value-Add

FPV Ventures’ leadership role is particularly telling. As a specialist in enterprise tech, FPV has a portfolio tilted toward AI agents that automate white-collar workflows, viewing Aily as a linchpin in the shift from reactive analytics to proactive decision-making. Insight Partners’ follow-on investment ensures continuity, leveraging their network for customer introductions—evident in Aily’s U.S. foothold. J.P. Morgan’s stake, meanwhile, could open doors to banking and asset management clients, where Aily’s tools for risk modeling and portfolio optimization align seamlessly.

This syndicate’s composition—blending growth-stage VCs with corporate strategics—mitigates risks in a market where 70% of AI pilots fail due to integration hurdles. It also positions Aily for potential M&A, whether acquiring complementary data orchestration tools or forging alliances with hyperscalers like AWS or Azure.

Competitive Landscape and Market Dynamics

Aily Labs operates in the $28.5 billion AI decision intelligence market by 2028, a segment exploding at 40% CAGR as enterprises grapple with data overload and regulatory pressures. Competitors range from incumbents like Palantir (focused on government/defense) and C3.ai (predictive maintenance) to nimbler players like DataRobot and H2O.ai. Aily differentiates through its “super agent” architecture—autonomous systems that chain LLMs with domain-specific models for end-to-end decisions—delivering ROI in weeks, not months. Unlike broader platforms, Aily’s emphasis on Fortune 500 silos (e.g., integrating ERP with CRM) addresses a pain point: 80% of executives report decision delays from fragmented data.

Challenges persist: Legacy system compatibility remains a barrier, and ethical AI governance (e.g., bias in agentic decisions) could draw scrutiny in regulated sectors. Yet, with Nvidia’s ecosystem tailwinds and a post-ChatGPT surge in agent adoption, Aily’s timing is impeccable. This funding could propel market share gains, targeting 10-15% penetration in pharma and finance by 2027.

Future Outlook and Broader Implications

Looking ahead, the $80 million positions Aily Labs for aggressive scaling: expect 100-150 new hires in sales, engineering, and R&D, plus deeper integrations with emerging multimodal AI. Global expansion—beyond Europe and North America—could include Asia-Pacific outposts, capitalizing on manufacturing digitization. For stakeholders, this round validates AI’s enterprise pivot from experimentation to operational core, potentially inspiring similar investments in “quiet AI” tools that enhance human judgment rather than replace it.

In a landscape where AI funding dipped 20% in 2024 before rebounding, Aily’s haul exemplifies resilience. It not only fortifies the company’s runway to $100 million+ ARR but also contributes to a narrative of sustainable AI growth, where profitability and client wins trump speculative valuations.

Please email us your feedback and news tips at hello(at)superbcrew.com